The global analysis of hospital discharges for systemic connective tissue disorders reveals that Poland leads with the highest share, followed by South Korea and France. Notable year-on-year growth in 2023 was observed in Poland, Mexico, and Slovenia, suggesting increasing healthcare engagement or recognition of these conditions. In contrast, Italy, the United Kingdom, and Iceland experienced declines, possibly indicating shifts in healthcare policy or diagnostic practices. Over the past five years, the compound annual growth rate has shown variability across countries, with Poland showing consistent growth, contrasting with declines in Iceland.
Future trends to watch include the potential impact of advancements in diagnostic technologies and treatment options on discharge rates. Additionally, demographic changes such as aging populations and varying healthcare approaches across countries may influence future statistical patterns. Monitoring these factors will be crucial for understanding the global landscape of connective tissue disorder management.
Top countries in Hospital Discharges for Systemic Connective Tissue Disorders Share by Country (Units (Hospital Discharges))
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Poland | 23.41 | 2023 | +10.91% | +1.64% | View data |
| 2 | 2 South Korea | 17.33 | 2023 | +7.56% | +0.89% | View data |
| 3 | 3 France | 16.9 | 2023 | +2.17% | +0.75% | View data |
| 4 | 4 Italy | 8.15 | 2023 | +1.15% | -3.25% | View data |
| 5 | 5 Hungary | 6.26 | 2023 | +8.71% | +0.25% | View data |
| 6 | 6 United Kingdom | 6.08 | 2023 | -1.86% | -1.85% | View data |
| 7 | 7 Mexico | 6.05 | 2023 | +10.63% | +1.32% | View data |
| 8 | 8 Australia | 4.62 | 2023 | +0.7% | +0.3% | View data |
| 9 | 9 Austria | 3.79 | 2023 | +1.31% | -1.65% | View data |
| 10 | 10 Sweden | 2.98 | 2023 | +0.76% | -1.64% | View data |
